Literature DB >> 8671136

Shared care: a review of the literature.

J P Hampson1, R I Roberts, D A Morgan.   

Abstract

This review examines broad issues of concern regarding the primary/secondary care interface. The main purpose was to identify areas of good practice which could be adapted for more general use. One of the most fundamental aspects identified was communication, which is discussed in some detail. Also covered are shared prescribing and disease management. The data suggest that the most effective system(s) of shared care has yet to be established. Further qualitative and economic evaluations are required, taking into account patient preferences. Although the literature does describe certain practice exemplars, it is clear that inter- and intra-professional communication continues to be a problem. Whilst information technology may provide some of the solutions, it is concluded that a culture change, which compels health professionals to make sharing of patient information a much higher priority, is required.

Entities:  

Mesh:

Year:  1996        PMID: 8671136     DOI: 10.1093/fampra/13.3.264

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  13 in total

1.  Prescribing at the interface between primary and secondary care in the UK. Towards joint formularies?

Authors:  M Duerden; T Walley
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

2.  Adoption of disease management model for diabetes in region of Maastricht.

Authors:  H J Vrijhoef; C Spreeuwenberg; I M Eijkelberg; B H Wolffenbuttel; G G van Merode
Journal:  BMJ       Date:  2001-10-27

3.  Communication at the interface: do better referral letters produce better consultant replies?

Authors:  Richard Grol; Noor Rooijackers-Lemmers; Leo van Kaathoven; Huub Wollersheim; Henk Mokkink
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

4.  Guideline sheets on the side effects of anticancer drugs are useful for general practitioners.

Authors:  Marie-Eve Rouge-Bugat; Donia Lassoued; Joy Bacrie; Nathalie Boussier; Jean-Pierre Delord; Stéphane Oustric; Eric Bauvin; Maryse Lapeyre-Mestre; François Bertucci; Pascale Grosclaude
Journal:  Support Care Cancer       Date:  2015-03-27       Impact factor: 3.603

5.  An information system to support the care for head and neck cancer patients.

Authors:  Jaap L van den Brink; Peter W Moorman; Maarten F de Boer; Jan H van Bemmel; Jean F A Pruyn; Carel D A Verwoerd
Journal:  Support Care Cancer       Date:  2003-04-18       Impact factor: 3.603

6.  The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.

Authors:  James E Egan; Paul Casadonte; Tracy Gartenmann; Judith Martin; Elinore F McCance-Katz; Julie Netherland; John A Renner; Linda Weiss; Andrew J Saxon; David A Fiellin
Journal:  J Gen Intern Med       Date:  2010-05-11       Impact factor: 5.128

7.  Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital.

Authors:  J D Nielsen; T Palshof; J Mainz; A B Jensen; F Olesen
Journal:  Qual Saf Health Care       Date:  2003-08

8.  Relationships between family physicians' referral for palliative radiotherapy, knowledge of indications for radiotherapy, and prior training: a survey of rural and urban family physicians.

Authors:  Robert A Olson; Sonca Lengoc; Scott Tyldesley; John French; Colleen McGahan; Jenny Soo
Journal:  Radiat Oncol       Date:  2012-05-18       Impact factor: 3.481

9.  Infrastructural arrangements for integrated care: implementing an electronic nursing plan in a psychogeriatric ward.

Authors:  Gunnar Ellingsen; Glenn Munkvold
Journal:  Int J Integr Care       Date:  2007-05-16       Impact factor: 5.120

10.  "When patients have cancer, they stop seeing me"--the role of the general practitioner in early follow-up of patients with cancer--a qualitative study.

Authors:  Tor Anvik; Knut A Holtedahl; Hege Mikalsen
Journal:  BMC Fam Pract       Date:  2006-03-21       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.